UPDATE : Monday, February 17, 2020
상단여백
AbbVie's releases new data for chronic lymphocytic leukemia treatment by Lee Han-soo 2019-12-09 17:42
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment by Lee Han-soo 2019-12-09 16:15
Genematrix wins CE certification for respiratory disease virus detection kit by Lee Han-soo 2019-12-09 15:36
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval? by Kim Yun-mi 2019-12-09 14:39
New MSD labor union launched with fresh resolve by Jeong Sae-im 2019-12-09 14:37
라인
Celltrion unveils long-term P3 trial results for Truxima in US by Lee Han-soo 2019-12-09 10:36
AMC unravels clues in treating relapsing, metastatic bladder cancer by Lee Han-soo 2019-12-06 18:22
Gemvax & Kael unveils P2 trial result for Alzheimer treatment by Lee Han-soo 2019-12-06 17:06
Syntekabio, CHA Hospital to co-develop immunotherapy by Lee Han-soo 2019-12-06 16:32
Medpacto vows to become global company specializing in biomarker-based drugs by Lee Han-soo 2019-12-06 15:03
라인
China OKs Humedix's hyaluronic acid filler by Lee Han-soo 2019-12-06 15:02
‘Endogenous T cells have high potential of treating blood, solid tumors’ by Lee Han-soo 2019-12-06 12:41
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports by Lee Han-soo 2019-12-05 15:04
Macrogen’s research on Asian genomic database becomes cover story of Nature by Lee Han-soo 2019-12-05 11:54
‘Obesity treatment will drastically change next few years’ by Lee Han-soo 2019-12-04 18:20
라인
'Insulin is safe, natural replacement therapy for diabetic patients' by Lee Han-soo 2019-12-04 17:07
Hanmi licenses in US firm’s oral immunotherapy candidate by Lee Han-soo 2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia by Lee Han-soo 2019-12-04 16:16
Swedish researchers divide Type 2 diabetes into 5 subgroups by Lee Han-soo 2019-12-03 17:45
Ildong signs co-promotion contract with GSK Consumer Healthcare by Lee Han-soo 2019-12-03 15:18
여백
여백
여백
Back to Top